To Determine the Relationship Between Baseline Reversibility and the Efficacy of Indacaterol

Summary

In this 5-months study, the response of patients to salbutamol at baseline will be compared with their response to treatment with indacaterol.

Timeline

Start

2010-04

Primary completion

2012-05

Completion

2012-05

Publications

• Burgel PR, Le Gros V, Decuypere L, Bourdeix I, Perez T, Deslee G. Immediate salbutamol responsiveness does not predict long-term benefits of indacaterol in patients with chronic obstructive pulmonary disease. BMC Pulm Med. 2017 Jan 31;17(1):25. doi: 10.1186/s12890-017-0372-z.

Drugs

Indications